InsidersTradesSigma
Browse the complete record of transactions filed by Sobel Alan D., Director. Director active across 1 company, notably Cytosorbents Corp. Aggregated, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 14 February 2022. The latest transaction was filed on 11 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Alan D. Sobel is a Board Member at Cytosorbents Corp. He contributes to the governance of the company, which specializes in medical technologies. His expertise is valuable in guiding strategic decisions for Cytosorbents.